Inventor · disambiguated record
Chase C. Smith
Also filed as: SMITH CHASE · SMITH CHASE C
30 granted patents·13 pending applications·341 citations·filing 1994–2024
97Inventor score
Top patents by PatentIndex Score
43 records- 0197US11980611B2Treating sickle cell disease with a pyruvate kinase R activating compoundNOVO NORDISK HEALTHCARE AG·Filed 2022·Granted May 14, 2024·3 cites·4 claims
- 0297US11649242B2Pyrrolopyrrole compositions as pyruvate kinase (PKR) activatorsFORMA THERAPEUTICS INC·Filed 2021·Granted May 16, 2023·5 cites·4 claims
- 0396US11014927B2Pyrrolopyrrole compositions as pyruvate kinase (PKR) activatorsFORMA THERAPEUTICS INC·Filed 2018·Granted May 25, 2021·6 cites·3 claims
- 0496US5405972ASynthetic process for the preparation of taxol and other tricyclic and tetracyclic taxanesUNIV FLORIDA STATE·Filed 1994·Granted Apr 11, 1995·79 cites·7 claims
- 0595US10772874B2Compounds and compositions for the inhibition of NAMPTFORMA TM LLC·Filed 2019·Granted Sep 15, 2020·6 cites·11 claims
- 0694US9676721B2Compounds and compositions for the inhibition of NAMPTBAIR KENNETH W·Filed 2011·Granted Jun 13, 2017·33 cites·7 claims
- 0793US10647695B2Compounds and compositions for the inhibition of NAMPTFORMA TM LLC·Filed 2019·Granted May 12, 2020·5 cites·7 claims
- 0893US10272072B2Compounds and compositions for the inhibition of NAMPTFORMA TM LLC·Filed 2016·Granted Apr 30, 2019·11 cites·19 claims
- 0992US9169209B2Compounds and compositions for the inhibition of NAMPTBAIR KENNETH W·Filed 2011·Granted Oct 27, 2015·25 cites·22 claims
- 1091US11547701B2Compounds and compositions for the inhibition of NAMPTVALO HEALTH INC·Filed 2020·Granted Jan 10, 2023·2 cites·11 claims
- 1191US11279687B2Compounds and compositions for the inhibition of NAMPTVALO HEALTH INC·Filed 2020·Granted Mar 22, 2022·2 cites·9 claims
- 1291US10456382B2Compounds and compositions for the inhibition of NAMPTFORMA TM LLC·Filed 2018·Granted Oct 29, 2019·7 cites·20 claims
- 1391US10329275B2Compounds and compositions for the inhibition of NAMPTFORMA TM LLC·Filed 2018·Granted Jun 25, 2019·8 cites·10 claims
- 1490US9555039B2Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT)BAIR KENNETH W·Filed 2011·Granted Jan 31, 2017·13 cites·19 claims
- 1590US2024391922A1Pyrrolopyrrole compositions as pyruvate kinase (pkr) activatorsNovo Nordisk Heathcare AG·Filed 2024·Application pending·0 cites
- 1688US12071440B2Pyrrolopyrrole compositions as pyruvate kinase (PKR) activatorsNOVO NORDISK HEALTHCARE AG·Filed 2023·Granted Aug 27, 2024·0 cites·4 claims
- 1788US7230101B1Synthesis of methotrexate-containing heterodimeric moleculesGPC BIOTECH INC·Filed 2003·Granted Jun 12, 2007·20 cites·5 claims
- 1886US8518958B2Pyrido [2,3-D] pyrimidines and their use as kinase inhibitorsMURTHI KRISHNA K·Filed 2007·Granted Aug 27, 2013·9 cites·31 claims
- 1985US11479564B2Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT)VALO HEALTH INC·Filed 2020·Granted Oct 25, 2022·1 cites·7 claims
- 2085US8450348B2Derivatives of squaric acid with anti-proliferative activityMURTHI KRISHNA K·Filed 2007·Granted May 28, 2013·16 cites·13 claims
- 2185US5637732ATricyclic and tetracyclic taxanesUNIV FLORIDA STATE·Filed 1995·Granted Jun 10, 1997·26 cites·11 claims
- 2283US12336981B2Compounds and compositions for the inhibition of NAMPTVALO HEALTH INC·Filed 2022·Granted Jun 24, 2025·0 cites·11 claims
- 2383US6861537B2Tricyclic and tetracyclic taxane intermediatesUNIV FLORIDA STATE·Filed 2002·Granted Mar 1, 2005·8 cites·18 claims
- 2481US10696692B2Amido-benzyl sulfone and sulfoxide derivatesFORMA TM LLC·Filed 2013·Granted Jun 30, 2020·6 cites·4 claims
- 2579US5760252ASynthetic process for the preparation of tricyclic and tetracyclic taxanesUNIV FLORIDA STATE·Filed 1996·Granted Jun 2, 1998·17 cites·18 claims
- 2678US5618952ASynthetic process for the preparation of tricyclic and tetracyclic taxanesUNIV FLORIDA STATE·Filed 1995·Granted Apr 8, 1997·16 cites·11 claims
- 2778US2023110003A1Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (nampt)VALO HEALTH INC·Filed 2022·Application pending·0 cites
- 2875US12053458B2Treating sickle cell disease with a pyruvate kinase R activating compoundNOVO NORDISK HEALTHCARE AG·Filed 2019·Granted Aug 6, 2024·0 cites·12 claims
- 2973US6005120ATricyclic and tetracyclic taxanesUNIV FLORIDA STATE·Filed 1997·Granted Dec 21, 1999·12 cites·16 claims
- 3067US2014163006A1Pyrido-[2,3-D] Pyrimidines and Their Use as Kinase InhibitorsFORMA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3167US2014163223A1Pyrido-[2,3-D] Pyrimidines and Their Use as Kinase InhibitorsFORMA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3266US2014163003A1Pyrido-[2,3-D] Pyrimidines and Their Use as Kinase InhibitorsMURTHI KRISHNA·Filed 2013·Application pending·0 cites
- 3364US8232283B2Raf inhibitorsSCHOOP ANDREAS·Filed 2011·Granted Jul 31, 2012·2 cites·11 claims
- 3463US2014163005A1Pyrido-[2,3-D] Pyrimidines and Their Use as Kinase InhibitorsFORMA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3563US2014163004A1Pyrido-[2,3-D] Pyrimidines and Their Use as Kinase InhibitorsFORMA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3663US2014163007A1Pyrido-[2,3-D] Pyrimidines and Their Use as Kinase InhibitorsFORMA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3762US6433189B2Tricyclic and tetracyclic taxane intermediatesUNIV FLORIDA STATE·Filed 2001·Granted Aug 13, 2002·2 cites·10 claims
- 3861US2014163222A1Pyrido-[2,3-D] Pyrimidines and Their Use as Kinase InhibitorsFORMA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3961US2019031686A1Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (nampt)FORMA TM LLC·Filed 2018·Application pending·0 cites
- 4058US2014294805A1Novel compounds and compositions for the inhibition of namptBAIR KENNETH W·Filed 2011·Application pending·0 cites
- 4158US2017137441A1Piperidine Derivatives And Compositions For the Inhibition Of Nicotinamide Phosphoribosyltransferase (NAMPT)BAIR KENNETH W·Filed 2017·Application pending·0 cites
- 4255US2013273034A1Novel compounds and compositions for the inhibition of namptBAIR KENNETH W·Filed 2011·Application pending·0 cites
- 4342US6278026B1Intermediates for tricyclic or tetracyclic taxanesUNIV FLORIDA STATE·Filed 1999·Granted Aug 21, 2001·1 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Chase C. Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →